Works matching IS 13518216 AND DT 2023 AND VI 29 AND IP 6
Results: 38
Joint status, pain and quality of life in elderly people with haemophilia: A case‐control study.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1621, doi. 10.1111/hae.14890
- By:
- Publication type:
- Article
Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1638, doi. 10.1111/hae.14891
- By:
- Publication type:
- Article
Bone marrow oedema syndrome as a cause of chronic knee pain in a person with severe Haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1668, doi. 10.1111/hae.14889
- By:
- Publication type:
- Article
Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1661, doi. 10.1111/hae.14873
- By:
- Publication type:
- Article
Five new F10 variants in hereditary factor x deficiency detected by high‐throughput sequencing.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1565, doi. 10.1111/hae.14888
- By:
- Publication type:
- Article
Identifying performance‐based outcome measures of physical function in people with haemophilia (IPOP).
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1611, doi. 10.1111/hae.14886
- By:
- Publication type:
- Article
Neuroinflammatory markers in patients with haemophilia and healthy controls: Where are the differences?
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1539, doi. 10.1111/hae.14881
- By:
- Publication type:
- Article
Preclinical development and characterization of a human plasma‐derived high‐purity factor X concentrate for therapeutic use.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1394, doi. 10.1111/hae.14875
- By:
- Publication type:
- Article
Does the method of telehealth delivery affect the physiotherapy management of adults with bleeding disorders? A comparison of audioconferencing and videoconferencing.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1589, doi. 10.1111/hae.14869
- By:
- Publication type:
- Article
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1442, doi. 10.1111/hae.14887
- By:
- Publication type:
- Article
The ISTH‐BAT score and outcomes after endometrial ablation in women with heavy menstrual bleeding.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1573, doi. 10.1111/hae.14872
- By:
- Publication type:
- Article
A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non‐factor VIII related haemostasis assays.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1633, doi. 10.1111/hae.14884
- By:
- Publication type:
- Article
Patient‐centred research agenda for females with bleeding disorders.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1665, doi. 10.1111/hae.14883
- By:
- Publication type:
- Article
How does joint impairment affect the functional capacity of the lower limb in early haemophilia‐related arthropathy?
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1604, doi. 10.1111/hae.14871
- By:
- Publication type:
- Article
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1499, doi. 10.1111/hae.14880
- By:
- Publication type:
- Article
The World Health Organisation's list of essential medicines and haemophilia treatment products.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1387, doi. 10.1111/hae.14879
- By:
- Publication type:
- Article
A national assessment of standards of care for inherited bleeding disorders in Canada.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1450, doi. 10.1111/hae.14878
- By:
- Publication type:
- Article
The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1529, doi. 10.1111/hae.14877
- By:
- Publication type:
- Article
Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1519, doi. 10.1111/hae.14876
- By:
- Publication type:
- Article
Mobilization under anaesthesia for correction of knee flexion deformity in haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1597, doi. 10.1111/hae.14870
- By:
- Publication type:
- Article
Guidance for the antithrombotic management of persons with haemophilia and cardiovascular disease.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1390, doi. 10.1111/hae.14874
- By:
- Publication type:
- Article
Delivery of gene therapy in haemophilia treatment centres in the United States: Practical aspects of preparedness and implementation.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1430, doi. 10.1111/hae.14867
- By:
- Publication type:
- Article
Targeting higher factor VIII levels for prophylaxis in haemophilia A: a narrative review.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1419, doi. 10.1111/hae.14866
- By:
- Publication type:
- Article
Initial von Willebrand factor antigen values in adolescent females predict future values.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1547, doi. 10.1111/hae.14865
- By:
- Publication type:
- Article
Cases of less‐than‐expected FVIII activity in previously treated patients during post‐marketing surveillance of N8‐GP.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1475, doi. 10.1111/hae.14864
- By:
- Publication type:
- Article
Treatment‐related outcome from patient report outcome (PRO) of children with severe and moderate hemophilia A in China: An analysis report of registration data from patient organization "hemophilia home care center".
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1467, doi. 10.1111/hae.14863
- By:
- Publication type:
- Article
Bridging the gap: Survey highlights challenges and solutions in outreach and identification of people with inherited bleeding disorders.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1456, doi. 10.1111/hae.14862
- By:
- Publication type:
- Article
Subclinical synovial proliferation in patients with severe haemophilia A: The value of ultrasound screening and biochemical markers.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1580, doi. 10.1111/hae.14861
- By:
- Publication type:
- Article
Prevalence and perceptions of pain in people with haemophilia: A UK study.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1509, doi. 10.1111/hae.14860
- By:
- Publication type:
- Article
Racial and ethnic differences in reported haemophilia death rates in the United States.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1410, doi. 10.1111/hae.14859
- By:
- Publication type:
- Article
How good does ChatGPT answer frequently asked questions about haemophilia?
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1646, doi. 10.1111/hae.14858
- By:
- Publication type:
- Article
Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1490, doi. 10.1111/hae.14857
- By:
- Publication type:
- Article
A 10‐year single‐institution retrospective review of treatment for acquired hemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1656, doi. 10.1111/hae.14856
- By:
- Publication type:
- Article
Characterization of a recombinant factor IX molecule fused to coagulation factor XIII‐B subunit.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1483, doi. 10.1111/hae.14855
- By:
- Publication type:
- Article
Development of VIII inhibitors beyond 50 exposure days to rFVIII during prophylactic emicizumab therapy.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1653, doi. 10.1111/hae.14854
- By:
- Publication type:
- Article
Adjunctive daratumumab can induce rapid remission in acquired haemophilia A with poor prognostic markers.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1649, doi. 10.1111/hae.14850
- By:
- Publication type:
- Article
Plasminogen, human‐tvmh for the treatment of children and adults with plasminogen deficiency type 1.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1556, doi. 10.1111/hae.14849
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1383, doi. 10.1111/hae.14601
- Publication type:
- Article